doi:10.3969/j.issn.1673-8640.2024.01.018

Abstract

CLC Number:

R733.71

Figures/Tables 3

References 12

[1]	ADÈS L, ITZYKSON R, FENAUX P. Myelodysplastic syndromes[J]. Lancet, 2014, 383(9936):2239-2252. DOI PMID
[2]	SEREFHANOGLU S, GOKER H, BUYUKASIK Y, et al. Transformation of adult myelodysplastic syndrome-refractory anemia to acute T-cell lymphoblastic leukemia[J]. J Natl Med Assoc, 2009, 101(4):370-372. PMID
[3]	SAN MIGUEL J F, HERNÁNDEZ J M, GONZÁLEZ-SARMIENTO R, et al. Acute leukemia after a primary myelodysplastic syndrome:immunophenotypic,genotypic,and clinical characteristics[J]. Blood, 1991, 78(3):768-774. DOI URL
[4]	ARBER D A, ORAZI A, HASSERJIAN R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia[J]. Blood, 2016, 127(20):2391-2405. DOI PMID
[5]	PORWIT A, BÉNÉ M C. Multiparameter flow cytometry applications in the diagnosis of mixed phenotype acute leukemia[J]. Cytom Part B-Clin Cytom, 2019, 96(3):183-194.
[6]	LI S, GARRETT-BAKELMAN F E, CHUNG S S, et al. Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia[J]. Nat Med, 2016, 22(7):792-799. DOI PMID
[7]	HEESCH S, NEUMANN M, SCHWARTZ S, et al. Acute leukemias of ambiguous lineage in adults:molecular and clinical characterization[J]. Ann Hematol, 2013, 92(6):747-758. DOI URL
[8]	YAN L, PING N, ZHU M, et al. Clinical,immunophenotypic,cytogenetic,and molecular genetic features in 117 adult patients with mixed-phenotype acute leukemia defined by WHO-2008 classification[J]. Haematologica, 2012, 97(11):1708-1712. DOI URL
[9]	KOTROVA M, MUSILOVA A, STUCHLY J, et al. Distinct bilineal leukemia immunophenotypes are not genetically determined[J]. Blood, 2016, 128(18):2263-2266. PMID
[10]	WEIR E G, ALI ANSARI-LARI M, BATISTA D A, et al. Acute bilineal leukemia:a rare disease with poor outcome[J]. Leukemia, 2007, 21(11):2264-2270. DOI
[11]	GERR H, ZIMMERMANN M, SCHRAPPE M, et al. Acute leukaemias of ambiguous lineage in children:characterization,prognosis and therapy recommendations[J]. Br J Haematol, 2010, 149(1):84-92. DOI URL
[12]	KIM M, ZANG D Y, LEE J, et al. Mixed phenotype acute leukemia that evolved from myelodysplastic syndrome with excess blasts[J]. Lab Med, 2020, 51(3):288-295. DOI URL

日期	白细胞/ （10⁹/L）	血红蛋白/ （g·L^-1）	血小板/ （10⁹/L）	骨髓原始细胞/%	原始细胞/ %	免疫表型
2019-12-05	1.56	87	195	1	4.86	CD45在髓系祖细胞上的表达减少，粒细胞比例降低，红系比例升高
2020-03-11	69.21	44	12	80	66.00	31.2%原始细胞：CD117、CD38阳性、部分 CD33、CD64阳性；31.8%原始细胞：CD19、cTDT、CD38、cCD79a阳性、部分 cCD22阳性
2020-04-30	1.44	93	21	20	43.00	10.1%原始细胞：CD34⁺CD117⁺CD38⁺CD123^-CD15^-；32.9%原始细胞：CD34⁺CD38⁺CD19⁺ cCD79a⁺ CD117^-CD10^-CD20^-
2020-05-17	3.12	61	12	<5%	0.40	异常的白血病相关免疫表型不存在
2020-06-19	1.16	95	63	15.5	29.93	21.2%原始细胞：CD19⁺CD7^-CD56^-CD117⁺CD15^-CD11b^-CD38⁺CD34⁺CD123⁺；8.73%原始细胞：CD19⁺CD7^-CD56^-CD117^-CD15^-CD11b^-CD38⁺CD34⁺CD123^-
2020-09-09	5.12	77	86	57	61.50	30.7%原始细胞：CD19⁺CD7^-CD56^-CD10^-CD20^-CD38⁺CD34⁺；30.8%原始细胞：CD117⁺CD19^-CD11b^-CD38⁺CD34⁺CD123^-
2020-09-24	2.13	73	40	21	46.03	12.3%原始细胞：CD7^-CD56^-CD117⁺CD15^-CD11b⁺CD38⁺CD34⁺CD123⁺；33.73%原始细胞：CD19⁺CD38⁺CD34⁺CD15^-CD11b^-CD117^-

日期	白细胞/ （10⁹/L）	血红蛋白/ （g·L^-1）	血小板/ （10⁹/L）	骨髓原始细胞/%	原始细胞/ %	免疫表型
2019-12-05	1.56	87	195	1	4.86	CD45在髓系祖细胞上的表达减少，粒细胞比例降低，红系比例升高
2020-03-11	69.21	44	12	80	66.00	31.2%原始细胞：CD117、CD38阳性、部分 CD33、CD64阳性；31.8%原始细胞：CD19、cTDT、CD38、cCD79a阳性、部分 cCD22阳性
2020-04-30	1.44	93	21	20	43.00	10.1%原始细胞：CD34⁺CD117⁺CD38⁺CD123^-CD15^-；32.9%原始细胞：CD34⁺CD38⁺CD19⁺ cCD79a⁺ CD117^-CD10^-CD20^-
2020-05-17	3.12	61	12	<5%	0.40	异常的白血病相关免疫表型不存在
2020-06-19	1.16	95	63	15.5	29.93	21.2%原始细胞：CD19⁺CD7^-CD56^-CD117⁺CD15^-CD11b^-CD38⁺CD34⁺CD123⁺；8.73%原始细胞：CD19⁺CD7^-CD56^-CD117^-CD15^-CD11b^-CD38⁺CD34⁺CD123^-
2020-09-09	5.12	77	86	57	61.50	30.7%原始细胞：CD19⁺CD7^-CD56^-CD10^-CD20^-CD38⁺CD34⁺；30.8%原始细胞：CD117⁺CD19^-CD11b^-CD38⁺CD34⁺CD123^-
2020-09-24	2.13	73	40	21	46.03	12.3%原始细胞：CD7^-CD56^-CD117⁺CD15^-CD11b⁺CD38⁺CD34⁺CD123⁺；33.73%原始细胞：CD19⁺CD38⁺CD34⁺CD15^-CD11b^-CD117^-

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 3

References 12

Related Articles 12

Recommended Articles

Metrics

[1]	. [J]. Laboratory Medicine, 2021, 36(12): 1292-1294.
[2]	. [J]. , 2007, 22(05): 574-577.
[3]	. [J]. , 2007, 22(02): 213-214.
[4]	. [J]. , 2006, 21(05): 533-536.
[5]	. [J]. , 2006, 21(04): 438-439.
[6]	. [J]. , 2006, 21(03): 254-258.
[7]	ZHANG Qiutang;LI Tao. Immunophenotyping of 201 adult patients with acute leukemia [J]. , 2005, 20(04): 373-375.
[8]	WU Jianguo;WU Mao;QIU Liannü;LIN Huijun;CHEN Zhimei;WANG Yungui. Report of a case of acute myeloid leukemia characterized by double t (8; 21 ) translocations [J]. , 2005, 20(02): 104-108.
[9]	. Study on the expression of ki-67 in acute leukemia [J]. , 2004, 19(06): 544-545.
[10]	. The expression and clinical significance of c-myc gene in bone marrow of acute myelogenous leukemia [J]. , 2000, 15(06): 329-330.
[11]	. [J]. , 2000, 15(05): 313-314.
[12]	. Fibrinolytic abnormalities in acute leukemia [J]. , 2000, 15(05): 296-297.